Medical Marijuana, Inc. (OTCPK:MJNA) reported Q2 results and released its OTC disclosure right as the market opened. The stock had gapped up following a huge two-day run (and a promotion by "Money Runners" late in the day on 8/12) but has now reversed, falling below the former key resistance level of $0.20 and declining more than 25% from the prior close. I had recently mentioned some very favorable near-term news, but had warned those considering investment to wait for Q2 results. The report had mostly bad news, but nothing detrimental. I continue to suggest that a better entry should be available in the future.
(click to enlarge)
This is the very high volume price action over the...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|